US2002116735A1PendingUtilityA1
Nucleic acids encoding a plant enzyme involved in very long chain fatty acid synthesis
Est. expiryApr 14, 2017(expired)· nominal 20-yr term from priority
C12N 15/8223C12N 9/1029C12N 15/8222C12N 15/8289C12N 15/8247
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Nucleic acid molecules encoding an enzyme involved in very long chain fatty acid (VLCFA) elongation in plants are disclosed. The invention includes a cDNA, genomic clone and encoded protein, as well as plants having modified VLCFA composition, such as modified epicuticular waxes, and methods of making such plants.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . An isolated nucleic acid molecule that encodes a protein having very long chain fatty acid elongase activity, wherein the nucleic acid molecule is selected from the group consisting of:
(a) nucleic acids comprising at least 15 consecutive nucleotides of the sequence set forth in Seq. I.D. No. 3; (b) nucleic acids possessing at least 70% sequence identity with the sequence set forth in Seq. I.D. No. 3; and (c) nucleic acids that hybridize under conditions of at least 70% stringency with the sequence set forth in Seq. I.D. No. 3.
2 . An isolated nucleic acid molecule according to claim 1 wherein the nucleic acid molecule comprises the sequence set forth in Seq. I.D. No. 3.
3 . An isolated nucleic acid molecule according to claim 1 wherein the nucleic acid molecule possess at least 80% sequence identity with the sequence set forth in Seq. I.D. No. 3:
4 . An isolated nucleic acid molecule according to claim 1 wherein the nucleic acid molecule hybridizes under conditions of at least 80% stringency with the sequence set forth in Seq. I.D. No. 3.
5 . A purified protein encoded by a nucleic acid molecule according to claim 1 .
6 . A recombinant vector comprising a nucleic acid molecule according to claim 1 .
7 . A recombinant vector according to claim 6 wherein the nucleic acid molecule is in reverse orientation relative to an adjacent promoter sequence of the vector.
8 . A transgenic plant comprising a recombinant vector according to claim 6 .
9 . A transgenic plant comprising a recombinant vector according to claim 7 .
10 . A transgenic plant comprising a recombinant expression cassette comprising a promoter sequence operably linked to a nucleic acid sequence selected from the group consisting of:
(a) nucleic acids comprising at least 15 consecutive nucleotides of the sequence set forth in Seq. I.D. No. 1; (b) nucleic acids possessing at least 70% sequence identity with the sequence set forth in Seq. I.D. No. 3; and (c) nucleic acids that hybridize under conditions of at least 70% stringency with the sequence set forth in Seq. I.D. No. 3.
11 . A transgenic plant according to claim 10 wherein the nucleic acid sequence comprises at least 30 consecutive nucleotides of the sequence set forth in Seq. I.D. No. 1.
12 . A transgenic plant according to claim 10 wherein the nucleic acid sequence possess at least 80% sequence identity with the sequence set forth in Seq. I.D. No. 3.
13 . A transgenic plant according to claim 10 wherein the nucleic acid sequence hybridizes under conditions of at least 80% stringency with the sequence set forth in Seq. I.D. No. 3.
14 . A transgenic plant according to claim 10 , wherein the plant has a modified phenotype compared to a non-transgenic plant of the same species.
15 . A transgenic plant according to claim 14 wherein the modified phenotype is a modified very long chain fatty acid composition.
16 . A transgenic plant according to claim 15 wherein the modified phenotype is a modified epicuticular wax layer.
17 . A transgenic plant according to claim 14 wherein the modified phenotype is modified seed oil composition.
18 . A transgenic plant according to claim 14 wherein the modified phenotype is conditional male sterility.
17 . A method of producing a plant with a modified very long chain fatty acid composition relative to a non-transgenic plant of the same species, comprising introducing into the plant a recombinant vector according to claim 6 .
18 . A transgenic plant produced by the method of claim 17 .
19 . A transgenic plant produced by sexual or asexual propagation of a plant according to claim 18 or the progeny of said plant.
20 . An isolated nucleic acid molecule having a nucleotide sequence according to Seq. I.D. No. 3.
21 . An isolated nucleic acid molecule that encodes a protein having an amino acid sequence as shown in Seq. I.D. No. 4.
24 . A method of isolating a nucleic acid molecule encoding a plant very long chain fatty acid elongation enzyme, the method comprising hybridizing a nucleic acid preparation with a DNA molecule comprising at least 15 consecutive nucleotides of the sequence set forth in Seq. I.D. No. 1.
25 . An isolated nucleic acid molecule isolated according to the method of claim 24 .
26 . A recombinant nucleic acid molecule comprising a promoter sequence operably linked to a nucleic acid sequence, wherein the promoter sequence comprises a CUT1 promoter.
27 . A recombinant nucleic acid molecule according to claim 26 wherein the promoter sequence comprises at least 50 consecutive nucleotides of the sequence shown in Seq. I.D. No.12.
28 . A purified peptide having an amino acid sequence that is at least 70% identical to the sequence set forth in Seq. I.D. No. 4.Join the waitlist — get patent alerts
Track US2002116735A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.